AU2003219291A1 - Bicyclic compounds useful as angiotensin ii agonists - Google Patents
Bicyclic compounds useful as angiotensin ii agonistsInfo
- Publication number
- AU2003219291A1 AU2003219291A1 AU2003219291A AU2003219291A AU2003219291A1 AU 2003219291 A1 AU2003219291 A1 AU 2003219291A1 AU 2003219291 A AU2003219291 A AU 2003219291A AU 2003219291 A AU2003219291 A AU 2003219291A AU 2003219291 A1 AU2003219291 A1 AU 2003219291A1
- Authority
- AU
- Australia
- Prior art keywords
- angiotensin
- agonists
- compounds useful
- bicyclic compounds
- bicyclic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 229940123471 Angiotensin II agonist Drugs 0.000 title 1
- 125000002619 bicyclic group Chemical group 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/30—Hetero atoms other than halogen
- C07D333/34—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/GB2003/001251 WO2004085420A1 (en) | 2003-03-24 | 2003-03-24 | Bicyclic compounds useful as angiotensin ii agonists |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2003219291A1 true AU2003219291A1 (en) | 2004-10-18 |
Family
ID=33042165
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2003219291A Abandoned AU2003219291A1 (en) | 2003-03-24 | 2003-03-24 | Bicyclic compounds useful as angiotensin ii agonists |
Country Status (2)
| Country | Link |
|---|---|
| AU (1) | AU2003219291A1 (en) |
| WO (1) | WO2004085420A1 (en) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8067418B2 (en) | 2005-04-12 | 2011-11-29 | Vicore Pharma Ab | Tricyclic angiotensin II agonists |
| ES2395194T3 (en) | 2005-04-12 | 2013-02-11 | Vicore Pharma Ab | New tricyclic agonists of angiotensin II |
| JP5179349B2 (en) * | 2005-04-12 | 2013-04-10 | ヴィコール・ファルマ・アーベー | Novel bicyclic angiotensin II agonist |
| CA2690226C (en) | 2007-06-20 | 2012-07-24 | Mitsubishi Tanabe Pharma Corporation | Novel malonic acid sulfonamide derivative and pharmaceutical use thereof |
| ES2974690T3 (en) | 2010-11-05 | 2024-07-01 | Firmenich Incorporated | Useful compounds as TRPM8 modulators |
| WO2015152393A1 (en) | 2014-04-03 | 2015-10-08 | 国立研究開発法人国立循環器病研究センター | Medicine for suppressing malignant tumor metastasis |
| TW202140422A (en) | 2014-10-06 | 2021-11-01 | 美商維泰克斯製藥公司 | Modulators of cystic fibrosis transmembrane conductance regulator |
| WO2016107879A2 (en) * | 2014-12-30 | 2016-07-07 | Vicore Pharma Ab | New use of angiotensin ii receptor agonists |
| MX389514B (en) | 2015-10-01 | 2025-03-20 | Firmenich Incorporated | COMPOUNDS USEFUL AS TRANSIENT MELASTATIN POTENTIAL 8 RECEPTOR CHANNEL (TRPM8) MODULATORS. |
| ES2946970T3 (en) | 2016-03-31 | 2023-07-28 | Vertex Pharma | Transmembrane conductance regulator of cystic fibrosis modulators |
| BR112019006213A2 (en) | 2016-09-30 | 2019-06-18 | Vertex Pharma | cystic fibrosis transmembrane conductance regulator modulator, pharmaceutical compositions, treatment methods and process for making the modulator |
| LT3551622T (en) | 2016-12-09 | 2021-02-25 | Vertex Pharmaceuticals Incorporated | Modulator of cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulator |
| MA54105A (en) | 2017-06-08 | 2021-09-15 | Vertex Pharma | CYSTIC FIBROSIS TREATMENT METHODS |
| WO2019018395A1 (en) | 2017-07-17 | 2019-01-24 | Vertex Pharmaceuticals Incorporated | Methods of treatment for cystic fibrosis |
| CA3071278A1 (en) | 2017-08-02 | 2019-02-07 | Vertex Pharmaceuticals Incorporated | Processes for preparing pyrrolidine compounds |
| TWI719349B (en) | 2017-10-19 | 2021-02-21 | 美商維泰克斯製藥公司 | Crystalline forms and compositions of cftr modulators |
| WO2019113476A2 (en) | 2017-12-08 | 2019-06-13 | Vertex Pharmaceuticals Incorporated | Processes for making modulators of cystic fibrosis transmembrane conductance regulator |
| TWI810243B (en) | 2018-02-05 | 2023-08-01 | 美商維泰克斯製藥公司 | Pharmaceutical compositions for treating cystic fibrosis |
| US11414439B2 (en) | 2018-04-13 | 2022-08-16 | Vertex Pharmaceuticals Incorporated | Modulators of cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulator |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| YU78601A (en) * | 1999-05-05 | 2005-07-19 | Aventis Pharma Deutschland Gmbh. | 1-(p-thienylbenzyl)-imidazoles as angiotensin-(1-7) receptor agonists, method for the production and the utilization thereof and pharmaceutical preparations containing said compounds |
| CA2395088A1 (en) * | 1999-12-15 | 2001-06-21 | Bristol-Myers Squibb Company | Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists |
| DE10112041A1 (en) * | 2001-03-14 | 2002-09-26 | Aventis Pharma Gmbh | p-Thienylbenzylamides as agonists of angiotensin (1-7) receptors, processes for their preparation, their use and pharmaceutical compositions containing them |
| WO2002096883A1 (en) * | 2001-05-31 | 2002-12-05 | Vicore Pharma Ab | Tricyclic compounds useful as angiotensin ii agonists |
-
2003
- 2003-03-24 WO PCT/GB2003/001251 patent/WO2004085420A1/en not_active Ceased
- 2003-03-24 AU AU2003219291A patent/AU2003219291A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO2004085420A1 (en) | 2004-10-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2003257094A1 (en) | Substituted benzimidazole compounds | |
| AU2003302106A1 (en) | New tricyclic angiotensin ii agonists | |
| AU2003902860A0 (en) | Benzimidazole compounds | |
| AU2003302027A1 (en) | New tricyclic angiotensin ii agonists | |
| AU2003219291A1 (en) | Bicyclic compounds useful as angiotensin ii agonists | |
| AU2003286251A1 (en) | New bicyclic angiotensin ii agonists | |
| AU2003902380A0 (en) | Cephem compounds | |
| AU2003215635A1 (en) | Thiazol-2-yl-imine compounds as pde-7 inhibitors | |
| AU2003222206A1 (en) | Novel benzimidazole compounds | |
| AU2003205837A1 (en) | Tricyclic compounds useful as angiotensin ii agonists | |
| AU2003903629A0 (en) | New compound | |
| AU2003903205A0 (en) | New compound | |
| AU2003900207A0 (en) | New compounds | |
| AUPS058102A0 (en) | Imidazole compounds | |
| HK1094164A (en) | Heteroaryl-hydrazone compounds | |
| HK1085998A (en) | Substituted heterocyclic compounds | |
| AU2003906640A0 (en) | Heterocyclic compounds | |
| HK1088818A (en) | Novel compounds | |
| AU2003901012A0 (en) | Novel compounds | |
| HK1094969A (en) | Novel compounds | |
| HK1093198A (en) | Novel compounds | |
| HK1091829A (en) | Novel compounds | |
| HK1089753A (en) | Novel compounds | |
| HK1086276A (en) | Novel compounds | |
| AU2003904509A0 (en) | Novel Compounds |